Rite Aid, one of the largest pharmacy chains in the United States, has announced the closure of multiple locations in Washington state, including several Bartell Drugs stores, as part of its ongoing bankruptcy restructuring. The move marks another significant chapter in the financial struggles of the company, which filed for Chapter 11 bankruptcy protection in October 2023 amid growing debt and an evolving retail pharmacy landscape. The closures impact communities across the state, particularly in the Seattle area, where Bartell Drugs has been a local staple for over a century.
According to court filings, Rite Aid plans to shut down at least eight stores across Washington, including locations in Seattle, Bellevue, and Redmond. These closures are part of a broader national effort to eliminate underperforming stores and reduce operational costs as the company attempts to emerge from bankruptcy as a leaner, more sustainable organization. Bartell Drugs, which was acquired by Rite Aid in 2020, is included in the store reduction plan despite its strong brand presence in the Pacific Northwest.
The decision to close these locations follows a larger trend within the retail pharmacy industry, where brick-and-mortar chains have faced increasing pressure from rising competition, shrinking reimbursements, and changing consumer behaviors. Rite Aid’s financial challenges were further exacerbated by a wave of opioid-related lawsuits, supply chain disruptions, and shifts toward online pharmacy services. The company, which has more than $3 billion in debt, has been working with creditors and legal authorities to streamline operations while continuing to serve customers at its remaining locations.
Residents in affected neighborhoods have expressed concern over the closures, particularly those who rely on Bartell Drugs for prescriptions, vaccinations, and essential health services. Many of the soon-to-close stores were considered community fixtures, offering convenient access to healthcare and wellness products in urban and suburban areas alike. Local leaders and healthcare advocates worry that the closures could create pharmacy deserts, especially for vulnerable populations such as seniors, individuals with chronic illnesses, and those without reliable transportation.
Despite the store closures, Rite Aid has stated that it remains committed to maintaining operations at its stronger-performing locations. The company has also indicated plans to modernize remaining stores, improve digital services, and focus on delivering more personalized customer care as part of its turnaround strategy. Bartell Drugs locations that remain open are expected to be integrated more tightly with Rite Aid’s corporate operations, including shared technology platforms and supply chains.
While the closures are part of a financial necessity for Rite Aid, they mark a significant cultural and commercial shift for many Washington residents who have long associated Bartell Drugs with neighborhood convenience and community service. Founded in Seattle in 1890, Bartell Drugs has been known for its local identity and customer loyalty. The loss of these stores underscores the broader changes taking place in the pharmacy industry and the challenges faced by legacy brands in adapting to modern retail demands.
As the company navigates the bankruptcy process, additional closures may occur in the months ahead, depending on the outcome of financial negotiations and market conditions. Customers are encouraged to transfer prescriptions to nearby open locations or utilize Rite Aid’s online services for continued access to medications and healthcare products.
For now, Washington state braces for the impact of these closures as communities, employees, and customers adjust to the ongoing transformation of the pharmacy landscape. The closure of Rite Aid and Bartell Drugs stores represents more than just the loss of retail space—it reflects a shifting industry grappling with economic pressures and the evolving expectations of today’s healthcare consumer.
